Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rafael Escandon

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
European Heart Journal|March 7, 2021
The need for ethical and pragmatic strategies for sample and data collection during public health emergencies-minimizing missed opportunitiesRafael Escandon, Bettina Heidecker
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 19, 2023
Challenges in accelerated approvals for gene therapiesRafael Escandon, John Lantos
Mabs|May 29, 2014
Evaluation of cardiovascular parameters in cynomolgus monkeys following IV administration of LBR-101, a monoclonal antibody against calcitonin gene-related peptideSarah Walter, Abbas Alibhoy, Rafael Escandon, et al.
Cephalalgia : an International Journal of Headache|March 26, 2014
Cardiovascular and hemodynamic parameters in women following prolonged CGRP inhibition using LBR-101, a monoclonal antibody against CGRPMarcelo E Bigal, Sarah Walter, Michele Bronson, et al.
Pharmaceutical Medicine|December 17, 2022
Somatic Gene Therapy Research in Pediatric Populations: Ethical Issues and Guidance for Operationalizing Early Phase TrialsAlison Bateman-House, Lesha D Shah, Rafael Escandon, et al.
The American Journal of Bioethics : AJOB|February 27, 2024
Fetal Therapies and Clinical Research: Beyond Risk and BenefitLesha D Shah, John Lantos, Cara Hunt, et al.
Cephalalgia : an International Journal of Headache|December 25, 2013
Safety and tolerability of LBR-101, a humanized monoclonal antibody that blocks the binding of CGRP to its receptor: Results of the Phase 1 programMarcelo E Bigal, Rafael Escandon, Michele Bronson, et al.
Pediatrics|July 15, 2025
Improving the Pediatric Research Federal Review ProcessLauren N Jennings, Rafael Escandon, Douglas S Diekema, et al.
Leukemia & Lymphoma|April 11, 2015
The novel kinesin spindle protein (KSP) inhibitor SB-743921 exhibits marked activity in in vivo and in vitro models of aggressive large B-cell lymphomaDanielle Bongero, Luca Paoluzzi, Enrica Marchi, et al.
Gastro Hep Advances|August 12, 2024
A Novel Prescription Digital Therapeutic Option for the Treatment of Metabolic Dysfunction-Associated Steatotic Liver DiseaseNaim Alkhouri, Katherine Edwards, Mark Berman, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
European Heart Journal|March 7, 2021
The need for ethical and pragmatic strategies for sample and data collection during public health emergencies-minimizing missed opportunitiesRafael Escandon, Bettina Heidecker
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 19, 2023
Challenges in accelerated approvals for gene therapiesRafael Escandon, John Lantos
Mabs|May 29, 2014
Evaluation of cardiovascular parameters in cynomolgus monkeys following IV administration of LBR-101, a monoclonal antibody against calcitonin gene-related peptideSarah Walter, Abbas Alibhoy, Rafael Escandon, et al.
Cephalalgia : an International Journal of Headache|March 26, 2014
Cardiovascular and hemodynamic parameters in women following prolonged CGRP inhibition using LBR-101, a monoclonal antibody against CGRPMarcelo E Bigal, Sarah Walter, Michele Bronson, et al.
Pharmaceutical Medicine|December 17, 2022
Somatic Gene Therapy Research in Pediatric Populations: Ethical Issues and Guidance for Operationalizing Early Phase TrialsAlison Bateman-House, Lesha D Shah, Rafael Escandon, et al.
The American Journal of Bioethics : AJOB|February 27, 2024
Fetal Therapies and Clinical Research: Beyond Risk and BenefitLesha D Shah, John Lantos, Cara Hunt, et al.
Cephalalgia : an International Journal of Headache|December 25, 2013
Safety and tolerability of LBR-101, a humanized monoclonal antibody that blocks the binding of CGRP to its receptor: Results of the Phase 1 programMarcelo E Bigal, Rafael Escandon, Michele Bronson, et al.
Pediatrics|July 15, 2025
Improving the Pediatric Research Federal Review ProcessLauren N Jennings, Rafael Escandon, Douglas S Diekema, et al.
Leukemia & Lymphoma|April 11, 2015
The novel kinesin spindle protein (KSP) inhibitor SB-743921 exhibits marked activity in in vivo and in vitro models of aggressive large B-cell lymphomaDanielle Bongero, Luca Paoluzzi, Enrica Marchi, et al.
Gastro Hep Advances|August 12, 2024
A Novel Prescription Digital Therapeutic Option for the Treatment of Metabolic Dysfunction-Associated Steatotic Liver DiseaseNaim Alkhouri, Katherine Edwards, Mark Berman, et al.
Pageof 2